| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 50 | / | 2013 | ||||||||
| Date of issue: | 2013-04-22 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 50 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of Sopharma AD (the “Company") announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that the company ELPHARMA related to him, executed the following transactions related to shares in the Company: Date and time of the settlement Operation Number of shares Unit price (BGN) 17.4.2013 Sale 4 000 2.5500 17.4.2013 Sale 730 2.5500 17.4.2013 Sale 5 000 2.5500 17.4.2013 Sale 56 2.5500 17.4.2013 Sale 5 000 2.5500 17.4.2013 Sale 10 000 2.5500 17.4.2013 Sale 10 000 2.5500 17.4.2013 Sale 10 000 2.5500 17.4.2013 Sale 5 000 2.5800 18.4.2013 Sale 2 000 2.5800 18.4.2013 Sale 6 000 2.5800 18.4.2013 Sale 3 000 2.5800 19.4.2013 Sale 3 000 2.5700 19.4.2013 Sale 5 000 2.5700 19.4.2013 Sale 5 000 2.5700 19.4.2013 Sale 2 000 2.5600 19.4.2013 Sale 10 000 2.5600 22.4.2013 Sale 5 000 2.5450 22.4.2013 Sale 1 500 2.5150 22.4.2013 Sale 1 000 2.5160 22.4.2013 Sale 2 000 2.5010 22.4.2013 Sale 1 000 2.5150 22.4.2013 Sale 10 000 2.5150 22.4.2013 Sale 5 000 2.5200 22.4.2013 Sale 1 000 2.5350 23.4.2013 Sale 3 000 2.5340 23.4.2013 Sale 10 000 2.5300 23.4.2013 Sale 10 000 2.5300 23.4.2013 Sale 10 000 2.5350 23.4.2013 Sale 3 000 2.5450 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 50 re insiders transactions.doc | Current report 50 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-04-22 | Ognian Donev | Executive Director | |||
